Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NEOGEN CORPNEOG · Entity 4338 | Former CEO | October 27, 2025 | October 28, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NEOGEN CORP
Report date October 27, 2025 · Filed October 28, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 363,081 |
Ending reported balance
After 2025-10-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-10-27 · Exercise / conversion · Acquired 38,759 · Balance 371,608 Row 2 · 2025-10-27 · Tax withholding · Disposed 8,527 · Balance 363,081 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $6.19 · Expires 2025-10-27 | Direct | 38,759 |
Reported balance
After 2025-10-27 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-10-27 · Exercise / conversion · Disposed 38,759 · Balance 38,759 |
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
PATTERSON COMPANIES, INC.
Report date July 03, 2017 · Filed July 06, 2017
Section 16 reporting ended · disclosed 2017-07-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,271 |
Reported balance
After 2017-07-03 transaction · row 1
1 source rowRow 1 · 2017-07-03 · Tax withholding · Disposed 182 · Balance 1,271 F1: Represents shares of common stock withheld for payment of taxes incurred upon the lapse of restrictions on restricted stock units issued pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy ESOP | 100 |
Reported balance
Holding disclosure · report date 2017-07-03 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 100 F2: Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through April 30, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares of common stock withheld for payment of taxes incurred upon the lapse of restrictions on restricted stock units issued pursuant to the Patterson Companies, Inc. 2015 Omnibus Incentive Plan.
F2: Represents shares of common stock indirectly held by the Reporting Person's Employee Stock Ownership Plan (ESOP) account through April 30, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 27, 2025 Filed Oct 28, 2025 17:27 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 38,759 | $6.19 Strike: $6.19 | $239,918.21 |
DisclosureSEC source: 0000711377-25-000062 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,759 Underlying: Common Stock · 38,759 shares Expires 2025-10-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 17:27 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 8,527 | $6.19 | $52,782.13 |
DisclosureSEC source: 0000711377-25-000062 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 363,081 Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 17:27 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 38,759 | $6.19 | $239,918.21 |
DisclosureSEC source: 0000711377-25-000062 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 371,608 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2025 Filed Oct 14, 2025 18:59 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 3,063 | $6.04 Strike: $6.04 | $18,500.52 |
DisclosureSEC source: 0000711377-25-000046 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,063 Underlying: Common Stock · 3,063 shares Expires 2025-10-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 13, 2025 Filed Oct 14, 2025 18:59 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 865 | $6.04 | $5,224.60 |
DisclosureSEC source: 0000711377-25-000046 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 332,849 Read SEC document |
| October 13, 2025 Filed Oct 14, 2025 18:59 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 3,063 | $6.04 | $18,500.52 |
DisclosureSEC source: 0000711377-25-000046 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 333,714 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2025 Filed Oct 10, 2025 00:21 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 32,936 | $5.63 Strike: $5.63 | $185,429.68 |
DisclosureSEC source: 0000711377-25-000043 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 32,936 shares Expires 2025-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2025 Filed Oct 10, 2025 00:21 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 9,297 | $5.63 | $52,342.11 |
DisclosureSEC source: 0000711377-25-000043 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 330,651 Read SEC document |
| October 07, 2025 Filed Oct 10, 2025 00:21 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 32,936 | $5.63 | $185,429.68 |
DisclosureSEC source: 0000711377-25-000043 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Former CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 339,948 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 18:49 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 35,736 | $5.43 Strike: $5.43 | $194,046.48 |
DisclosureSEC source: 0000711377-25-000033 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 71,472 Underlying: Common Stock · 35,736 shares Expires 2025-08-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 18, 2025 Filed Aug 20, 2025 18:49 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 35,736 | $5.43 | $194,046.48 |
DisclosureSEC source: 0000711377-25-000033 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,012 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2025 Filed Apr 29, 2025 17:39 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 2,112 | $5.16 Strike: $5.16 | $10,897.92 |
DisclosureSEC source: 0000711377-25-000015 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,224 Underlying: Common Stock · 2,112 shares Expires 2025-04-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 28, 2025 Filed Apr 29, 2025 17:39 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 2,112 | $5.16 | $10,897.92 |
DisclosureSEC source: 0000711377-25-000015 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,276 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 16, 2025 Filed Jan 16, 2025 17:05 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 23,035 | $11.03 | $254,076.05 |
DisclosureSEC source: 0000711377-25-000001 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 269,164 Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:01 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 38,760 | $13.81 Strike: $13.81 | $535,275.60 |
DisclosureSEC source: 0000711377-24-000045 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,520 Underlying: Common Stock · 38,760 shares Expires 2024-10-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:01 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 11,280 | $13.81 | $155,776.80 |
DisclosureSEC source: 0000711377-24-000045 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,129 Read SEC document |
| October 28, 2024 Filed Oct 29, 2024 17:01 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 38,760 | $13.81 | $535,275.60 |
DisclosureSEC source: 0000711377-24-000045 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 15:51 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 3,064 | $14.43 Strike: $14.43 | $44,213.52 |
DisclosureSEC source: 0000711377-24-000034 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,127 Underlying: Common Stock · 3,064 shares Expires 2024-10-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 15:51 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 892 | $14.43 | $12,871.56 |
DisclosureSEC source: 0000711377-24-000034 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,649 Read SEC document |
| October 14, 2024 Filed Oct 15, 2024 15:51 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 3,064 | $14.43 | $44,213.52 |
DisclosureSEC source: 0000711377-24-000034 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,541 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 11, 2024 Filed Oct 15, 2024 13:21 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 14,500 | $13.80 | $200,100.00 |
DisclosureSEC source: 0000711377-24-000033 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,477 Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 17:35 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 32,937 | $15.07 Strike: $15.07 | $496,360.59 |
DisclosureSEC source: 0000711377-24-000030 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,936 Underlying: Common Stock · 32,937 shares Expires 2024-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 17:35 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 9,586 | $15.07 | $144,461.02 |
DisclosureSEC source: 0000711377-24-000030 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,977 Read SEC document |
| October 07, 2024 Filed Oct 9, 2024 17:35 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 32,937 | $15.07 | $496,360.59 |
DisclosureSEC source: 0000711377-24-000030 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:36 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock (Right to Buy) · Derivative | 784,636 | $0.00 Strike: $16.79 | $0.00 |
DisclosureSEC source: 0000711377-24-000019 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,129,279 Underlying: Common Stock · 784,636 shares Expires 2031-08-15 F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| August 15, 2024 Filed Aug 19, 2024 20:36 UTC | NEOGEN CORP NEOG · Entity 4338 | GrantCommon Stock | 107,207 | $16.79 | $1,800,005.53 |
DisclosureSEC source: 0000711377-24-000019 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 483,514 F1 · shares: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants F2 · balance_after: Includes 4,074 shares held as part of employee stock purchase plan Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 16:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 2,113 | $11.96 Strike: $11.96 | $25,271.48 |
DisclosureSEC source: 0000711377-24-000011 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,338 Underlying: Common Stock · 2,113 shares Expires 2024-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 16:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 615 | $11.96 | $7,355.40 |
DisclosureSEC source: 0000711377-24-000011 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,364 Read SEC document |
| April 25, 2024 Filed Apr 26, 2024 16:50 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 2,113 | $11.96 | $25,271.48 |
DisclosureSEC source: 0000711377-24-000011 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,979 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 23, 2024 Filed Apr 24, 2024 13:05 UTC | NEOGEN CORP NEOG · Entity 4338 | OtherCommon Stock | 17,477 | $12.09 | $211,296.93 |
DisclosureSEC source: 0000711377-24-000008 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 169,866 Read SEC document |
| April 23, 2024 Filed May 3, 2024 20:27 UTC Amendment | NEOGEN CORP NEOG · Entity 4338 | OtherCommon Stock | 17,899 | $11.81 | $211,369.29 |
DisclosureSEC source: 0000711377-24-000013 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,288 F1 · shares: Amount based on finalized transaction, which was executed as of 4/23/2024 Read SEC document |
| April 10, 2024 Filed Apr 10, 2024 18:25 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 23,000 | $12.36 | $284,190.30 |
DisclosureSEC source: 0000711377-24-000002 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 152,389 Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 15:38 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 116,279 | $0.00 Strike: $15.48 | $0.00 |
DisclosureSEC source: 0000711377-23-000016 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 199,794 Underlying: Common Stock · 116,279 shares Expires 2026-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 26, 2023 Filed Oct 31, 2023 15:38 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 698,251 | $0.00 Strike: $15.48 | $0.00 |
DisclosureSEC source: 0000711377-23-000016 · primary_doc.xml · derivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,965,248 Underlying: Common Stock · 698,251 shares Expires 2030-10-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| April 25, 2023 Filed Apr 27, 2023 17:24 UTC | NEOGEN CORP NEOG · Entity 4338 | Tax withholdingCommon Stock | 656 | $16.67 | $10,935.52 |
DisclosureSEC source: 0000711377-23-000005 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,907 F1 · kind: Shares surrendered to satisfy the tax obligations in connection with the April 25, 2023 vesting of restricted stock units. Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 21:13 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 90,361 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000025 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,689 Underlying: Common Stock · 90,361 shares Expires 2025-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| October 06, 2022 Filed Oct 11, 2022 21:13 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 625,001 | $0.00 Strike: $13.28 | $0.00 |
DisclosureSEC source: 0000711377-22-000025 · primary_doc.xml · derivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,266,997 Underlying: Common Stock · 625,001 shares Expires 2029-10-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs vest in equal annual installments on each of the first three anniversary dates of the grants Read SEC document |
| September 28, 2022 Filed Sep 28, 2022 21:27 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 22,000 | $14.37 | $316,140.00 |
DisclosureSEC source: 0000711377-22-000013 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,103 Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 18:28 UTC | NEOGEN CORP NEOG · Entity 4338 | PurchaseCommon Stock | 17,500 | $23.07 | $403,725.00 |
DisclosureSEC source: 0000711377-22-000009 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,103 Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:28 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 10,563 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0000711377-22-000007 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,144 Underlying: Common Stock · 10,563 shares Expires 2027-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs were each granted on 4/25/2022, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the respective grants Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:28 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 85,890 | $0.00 Strike: $28.40 | $0.00 |
DisclosureSEC source: 0000711377-22-000007 · primary_doc.xml · derivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 721,994 Underlying: Common Stock · 85,890 shares Expires 2027-05-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options and RSUs were each granted on 4/25/2022, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the respective grants Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 23:37 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionRestricted Stock Units · Derivative | 15,317 | $0.00 Strike: $40.85 | $0.00 |
DisclosureSEC source: 0000711377-21-000030 · primary_doc.xml · derivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,581 Underlying: Common Stock · 15,317 shares Expires 2026-10-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: RSUs have five year lives, vesting in equal annual installments on each of the first five anniversary dates of the grant Read SEC document |
| October 12, 2021 Filed Oct 14, 2021 23:37 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 150,352 | $0.00 Strike: $9.71 | $0.00 |
DisclosureSEC source: 0000711377-21-000030 · primary_doc.xml · derivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 636,104 Underlying: Common Stock · 150,352 shares Expires 2026-11-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The options have five year lives, and vest in equal annual installments on each of the first five anniversary dates of the grant Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 01:19 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 14,638 | $0.00 Strike: $63.90 | $0.00 |
DisclosureSEC source: 0000711377-21-000013 · primary_doc.xml · derivative · entry 5 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,876 Underlying: Common Stock · 14,638 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options were granted 10/11/2019, have five year lives, and vest in equal 20% annual installments on each of the first five anniversary dates of the grant Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 01:19 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 25,826 | $0.00 Strike: $62.70 | $0.00 |
DisclosureSEC source: 0000711377-21-000013 · primary_doc.xml · derivative · entry 4 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 257,514 Underlying: Common Stock · 25,826 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options were granted 11/1/2018, have rive year lives, and vest in equal annual 20% installments on each of the first five anniversary dates of the grant Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 01:19 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 40,464 | $87.99 | $3,560,394.99 |
DisclosureSEC source: 0000711377-21-000013 · primary_doc.xml · nonDerivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,080 Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 01:19 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 14,638 | $63.90 | $935,368.20 |
DisclosureSEC source: 0000711377-21-000013 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,544 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 31, 2021 Filed Apr 2, 2021 01:19 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock | 25,826 | $62.70 | $1,619,290.20 |
DisclosureSEC source: 0000711377-21-000013 · primary_doc.xml · nonDerivative · entry 1 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,906 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:40 UTC | NEOGEN CORP NEOG · Entity 4338 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 9,536 | $0.00 Strike: $62.70 | $0.00 |
DisclosureSEC source: 0000711377-21-000011 · primary_doc.xml · derivative · entry 3 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 283,340 Underlying: Common Stock · 9,536 shares Expires 2023-12-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options were granted 11/1/2018, have five year lives and vest in equal annual 20% installments on each of the first five anniversary dates of the grant Read SEC document |
| March 30, 2021 Filed Apr 1, 2021 22:40 UTC | NEOGEN CORP NEOG · Entity 4338 | SaleCommon Stock | 9,536 | $87.09 | $830,486.43 |
DisclosureSEC source: 0000711377-21-000011 · primary_doc.xml · nonDerivative · entry 2 ADENT JOHN EDWARD · CIK 0001651434 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,080 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.